News & Events

• July 12, 2018
  Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment

• July 12, 2018
  Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development

• July 5, 2018
  Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments

• June 22, 2018
  

  2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop

  WHAT: 2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop WHEN:   June 22, 2018 WHERE: FDA White Oak Campus, Silver Spring, MD CONTENT: This full day workshop is sponsored by the FDA Oncology Center of Excellence and will consist of four panels made up of international regulatory, payer, academic, patient, industry and policy leaders. Initial agenda planning is...
• May 18, 2018
  “Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK”